APA (7th ed.) Citation

Neumann, F., Kastrati, A., Miethke, T., Pogatsa-Murray, G., Mehilli, J., Valina, C., . . . Schömig, A. (2001). Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): A randomised, double-blind, placebo-controlled trial. Lancet, 357(9274), 2085. https://doi.org/10.1016/S0140-6736(00)05181-3

Chicago Style (17th ed.) Citation

Neumann, Franz-Josef, et al. "Treatment of Chlamydia Pneumoniae Infection with Roxithromycin and Effect on Neointima Proliferation After Coronary Stent Placement (ISAR-3): A Randomised, Double-blind, Placebo-controlled Trial." Lancet 357, no. 9274 (2001): 2085. https://doi.org/10.1016/S0140-6736(00)05181-3.

MLA (9th ed.) Citation

Neumann, Franz-Josef, et al. "Treatment of Chlamydia Pneumoniae Infection with Roxithromycin and Effect on Neointima Proliferation After Coronary Stent Placement (ISAR-3): A Randomised, Double-blind, Placebo-controlled Trial." Lancet, vol. 357, no. 9274, 2001, p. 2085, https://doi.org/10.1016/S0140-6736(00)05181-3.